Arriaga et al. showed that the overexpression of the MT1G sensitized colorectal cancer cells to the chemotherapeutic agents’ oxaliplatin and 5-fluorouracil, which may have been mediated by the activation of p53 and repression of NF-κB activity [108]. This evidence concerns the gene MT1G and colorectal cancer.